Table 1.
TP | 7.8 | g/dL | AFP | 941.8 | ng/mL |
Albumin | 4.8 | g/dL | AFP-L3 | 1.80 | % |
BUN | 11 | mg/dL | PIVKA-II | 1,170 | mAU/mL |
Cre | 0.49 | mg/dL | CEA | 0.5 | ng/mL |
AST | 18 | U/L | CA19-9 | 13.2 | U/mL |
ALT | 12 | U/L | HBsAg | (-) | |
γ-GTP | 16 | U/L | HBsAb | (-) | |
ALP | 216 | U/L | HBcAb | (-) | |
T-bil | 0.6 | mg/dL | HCVAb | (-) | |
LDH | 161 | U/L | IgG | 1,179 | mg/dL |
Na | 140 | mmol/L | IgM | 294 | mg/dL |
K | 3.8 | mmol/L | ANA | <40 | |
Cl | 106 | mmol/L | AMA | <20 | |
ChE | 263 | U/L | |||
HbA1c | 5.3 | % | Fe | 35.8 | ng/mL |
WBC | 9,320 | /μL | Cu | 107 | μg/dL |
RBC | 498×104 | /μL | TC | 204 | mg/dL |
Hb | 13.8 | g/dL | TG | 55 | mg/dL |
Plt | 26.4×104 | /μL | |||
PT-INR | 1.06 | % | |||
APTT | 42.2 | s |
TP: total protein, BUN: blood urea nitrogen, Cre: creatinine, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γ-GTP: γ-glutamyl transferase, ALP: alkaline phosphatase, T-bil: total bilirubin, LDH: lactate dehydrogenase, ChE: cholinesterase, WBC: white blood cell, RBC: red blood cell, Hb: hemoglobin, Plt: platelet, PT-INR: prothrombin time-international normalized ratio, APTT: activated partial thromboplastin time, AFP: alpha-fetoprotein, PIVKA-II: protein induced by vitamin K absence or antagonist II, HBsAg: hepatitis B surface antigen, HBsAb: hepatitis B surface antibody, HBcAb: hepatitis B core antibody, HCVAb: hepatitis C virus antibody, ANA: antinuclear antibody, AMA: anti-mitochondrial antibody, TC: total cholesterol, TG: triglyceride